AbbVie (ABBV) Prepaid Assets (2012 - 2026)
AbbVie (ABBV) reported Prepaid Assets of $6.6 billion for Q1 2026, up 20.27% year-over-year from $5.5 billion in Q1 2025, and up 5.04% quarter-over-quarter from $6.3 billion in Q4 2025.
AbbVie (ABBV) Prepaid Assets (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has 15 years of Prepaid Assets data on file, last reported at $6.6 billion in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.6 billion, up 20.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 billion (up 20.27% YoY), and the FY2025 annual result was $6.3 billion, up 27.72% from the prior year.
- Prepaid Assets improved to $6.6 billion in Q1 2026 per ABBV's latest filing, from $6.3 billion in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.6 billion in Q1 2026 and troughed at $4.4 billion in Q4 2022.
- A 5-year average of $5.0 billion and a median of $4.7 billion in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets dropped 11.86% in 2022, then climbed 27.72% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $4.4 billion in 2022, then gained by 12.07% to $4.9 billion in 2023, then declined by 0.1% to $4.9 billion in 2024, then advanced by 27.72% to $6.3 billion in 2025, then climbed by 5.04% to $6.6 billion in 2026.
- Business Quant data shows ABBV's Prepaid Assets at $6.6 billion in Q1 2026, $6.3 billion in Q4 2025, and $5.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.61 Bn |
| Dec 31, 2025 | 6.29 Bn |
| Sep 30, 2025 | 5.16 Bn |
| Jun 30, 2025 | 5.20 Bn |
| Mar 31, 2025 | 5.50 Bn |
| Dec 31, 2024 | 4.93 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Jun 30, 2024 | 4.72 Bn |
| Mar 31, 2024 | 4.61 Bn |
| Dec 31, 2023 | 4.93 Bn |
| Sep 30, 2023 | 4.54 Bn |
| Jun 30, 2023 | 4.54 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.51 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 4.99 Bn |
| Sep 30, 2021 | 4.33 Bn |
| Jun 30, 2021 | 4.10 Bn |